Feasibility of the Infra-Red Illumination for Facilitation of Video Scope-tracheal Intubation
Airway Morbidity, Covid19, Trachea
About this trial
This is an interventional treatment trial for Airway Morbidity focused on measuring Infra-Red Illumination, Retrograde Transcutaneous, videoscope-tracheal Intubation
Eligibility Criteria
Inclusion Criteria:
- Age above 18 years
- General anesthesia that needs endotracheal intubation
- All Mallampati score 1-3
- ASA physical status 1-3
Exclusion Criteria:
- Refuse or unable to sign the consent.
- Pregnancy
- Emergency cases
- History of or expected difficult intubation
- Maxillofacial abnormality or trauma
- Age below 18 years
- Rapid sequence induction
- Skin disorders and skin light sensitivity (SLE, Lupus ….)
- Impaired head and neck mobility
- Scars or skin injuries at the neck
Sites / Locations
- ACC&HGH, Hamad Medical CorporationRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Group A: control group (intubation without IRD/IRRIS device)
Intervention group using Infrared (Active IRD/ IRRIS) device
Group A = control group (intubation without IRD/IRRIS device) (15 subjects) The first operator experienced with video-laryngoscopy intubation will do the endotracheal intubation after induction of anesthesia.
Group B = intervention group using Infrared active IRD/IRRIS device (15 subjects) Before inducing anesthesia, the second operator will open the randomization envelope and adhere IRRIS/IRD device to the anterior skin of the neck above the sternal notch according to the group of patients. After confirming lack of discomfort during application of the IRRIS/IRD device, anesthesia will be induced